Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 22, 2003. The report primarily discloses changes in directors' interests and a share repurchase transaction authorized by shareholders at the Annual General Meeting on May 19, 2003.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate actions regarding share ownership and repurchases.
Material Changes
- Share Repurchase: On August 21, 2003, the company purchased 500,000 ordinary shares for cancellation at a price of 1,219.2877p per share.
- Directors' Interests: On August 20, 2003, the GlaxoSmithKline Employee Trust sold 1,565 ordinary shares on behalf of a participant in the Glaxo Wellcome 1999 Long Term Incentive Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the disclosed transactions.
Investor Verification Checklist
- Verify the total number of shares repurchased for cancellation (500,000) and the specific price per share (1,219.2877p).
- Confirm the authorization source for the repurchase (Annual General Meeting held May 19, 2003).
- Review the details of the GlaxoSmithKline Employee Trust transaction involving 1,565 shares sold on August 20, 2003.
- Note that this filing does not contain financial performance data; refer to Form 20-F for comprehensive financial statements.